[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371772-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371772-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-expression-of-transmembrane-channel-like-5-in-gastric-cancer-and-its-impact-on-tumor-progression","The expression of transmembrane channel-like 5 in gastric cancer and its impact on tumor progression","","Gastric cancer is a prevalent malignancy and its molecular drivers remain incompletely defined. Transmembrane channel-like 5 (TMC5) expression was examined using public database analyses, immunohistochemical staining, and Western blotting. TMC5 was overexpressed in gastric cancer tissues and cell lines, correlating with poor prognosis and adverse clinical features. Low mutation rates were observed, while methylation inversely related to expression. Functional experiments showed that TMC5 promotes proliferation, migration, invasion, and in vivo tumor growth and metastasis, linking to stemness, chemotherapy resistance, immune infiltration, immunotherapy response, and immune checkpoint genes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-expression-of-transmembrane-channel-like-5-in-gastric-cancer-and-its-impact-on-tumor-progression/371772/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-expression-of-transmembrane-channel-like-5-in-gastric-cancer-and-its-impact-on-tumor-progression/371772.png","ImageObject",300,407,{"name":42,"@type":43},"Grenda","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What methods were used to evaluate TMC5 expression in gastric cancer?","Question",{"text":63,"@type":64},"The study analyzed TMC5 expression using public databases, immunohistochemical assays, and Western blot analyses.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does TMC5 expression relate to clinical outcomes in gastric cancer?",{"text":68,"@type":64},"Higher TMC5 expression in gastric cancer tissues and cell lines is associated with poor prognosis and multiple unfavorable clinical characteristics.",{"name":70,"@type":61,"acceptedAnswer":71},"What functional effects does TMC5 have on gastric cancer cells and tumors?",{"text":72,"@type":64},"TMC5 promotes proliferation, migration, and invasion in vitro and enhances tumor growth and metastasis in vivo, and it is linked to stemness and chemotherapy resistance.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371772,1790472208,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971474921005,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nThe expression of transmembrane channel-like 5 in gastric cancer and its impact on tumor progression  \nYucai Wei1,2,5, Jiaxing Zhang2,3,5, Xiaomei Li2,3,5, Weijing Zhu2,3, Peng Zhang3,  \nHuijuan Cheng2, Qian Chen3, Zhongjie Wen3, Huanhuan Liu3, Lei Zhao2,4􀀍 & Yumin Li1,2􀀍  \nGastric cancer (GC) is a prevalent malignancy and one of the leading causes of cancer-related mortality worldwide. The role of transmembrane channel-like 5 (TMC5) in GC remains unknown. In this study, we analyzed the expression ofTMC5 in GC using a multi-faceted approach, including analysis of public databases, immunohistochemical assays, and Western blot analyses. Our results demonstrated that TMC5 was overexpressed in GC tissues and cell lines, which was associated with poor prognosis and various clinical characteristics. We observed that the mutation rates ofTMC5 in GC were low, and its methylation status was inversely related to its expression levels. Furthermore, functional assays demonstrated that TMC5 promoted GC cell proliferation, migration, and invasion in vitro, as well as tumor growth and metastasis in vivo. Furthermore, the TMC5 expression level was positively correlated with stemness and chemotherapy resistance in GC. Additionally, TMC5 was associated with multiple immune cell infiltration levels, immunotherapy response and immune checkpoint genes. Subsequently, the co-expression genes ofTMC5 in GC were screened and verified by qRT-PCR. Gene set enrichment analysis showed that these genes were mainly involved in biosynthesis, metabolic pathways, and multiple classic cancer-related signaling pathways. In conclusion, our study reveals the important role ofTMC5 in GC and provides potential new targets and strategies for the diagnosis and treatment of GC.  \nKeywords Gastric cancer, TMC5, Prognosis, Chemotherapy resistance, Immunotherapy response, Coexpression genes  \nGastric cancer (GC) remains a prevailing and lethal disease worldwide1. In China, GC is the fifth most common cancer and the third leading cause of cancer-related deaths2. The high mortality rate is largely attributed to the fact that GC patients usually diagnosed at an advanced stage and the complex molecular mechanisms driving tumor progression3,4. Chemotherapy is the most common treatment for GC patients, but its efficacy is limited5. In recent years, emerging strategies such as targeted therapy and immune checkpoint inhibitors have been recognized as promising new strategies to treat GC patients6,7. For instance, targeted therapies against human epidermal growth factor receptor 2 (HER2)8,9 and Claudin18.210 improve the prognosis of patients with advanced GC. However, not all patients benefit from anti-HER2 or anti-Claudin18.2 treatment, particularly those with negative HER2 or Claudin18.2 expression. Therefore, it is imperative to further elucidate the molecular mechanisms underlying GC progression fully so as to identify novel effective therapeutic targets11.  \nTMC5 is a member ofthe TMC protein family, which comprises eight members (TMC1-8) . Previous studies have highlighted the role ofthe TMC family in various cancers. For instance, Song et al. reported that TMC gene family are promising biomarkers for prognosis and immunotherapeutic response according to a pan-cancer analysis12. Lu et al. reported that TMC8 was highly expressed in hepatocellular carcinoma(HCC) and associated with poor prognosis13. Similarly, a pan-cancer analysis indicated that the expression level ofTMC5 is upregulated in a variety of tumors and closely related to prognosis and immune infiltration14. Zhang et al. found that TMC5 is highly expressed in prostate cancer, and silencing ofTMC5 inhibits the proliferation of prostate cancer cells15. TMC5 is also associated with the tumor microenvironment and prognosis of HCC16. Despite these findings, the role ofTMC5 in GC remains poorly understood, warranting further investigation.  \n1","cbCaitfzXbiCVFym","https://ap.wps.com/l/cbCaitfzXbiCVFym","pdf",3640794,15,"English","# Materials and methods\n## Bioinformatic analysis","[{\"question\":\"What methods were used to evaluate TMC5 expression in gastric cancer?\",\"answer\":\"The study analyzed TMC5 expression using public databases, immunohistochemical assays, and Western blot analyses.\"},{\"question\":\"How does TMC5 expression relate to clinical outcomes in gastric cancer?\",\"answer\":\"Higher TMC5 expression in gastric cancer tissues and cell lines is associated with poor prognosis and multiple unfavorable clinical characteristics.\"},{\"question\":\"What functional effects does TMC5 have on gastric cancer cells and tumors?\",\"answer\":\"TMC5 promotes proliferation, migration, and invasion in vitro and enhances tumor growth and metastasis in vivo, and it is linked to stemness and chemotherapy resistance.\"}]","The expression of transmembrane channel-like 5 in gastric cancer and its impact on tumor progression | PDF",1790192829,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b5898e8fc76c98734a6d88d989d13e67.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5529a0100f49c21b3e0123c8e00a2f9a.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/87dadbdcd71326f5325a0aa25e535d60.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a649f986ba17216e28a7dde5f91bd74e.webp",980,1287]